市場調查報告書
商品編碼
1434219
大麻市場:型態、產品類型、化合物、來源、分銷管道、應用 - 全球預測 2024-2030Cannabis Market by Form (Concentrated Oil, Cream, Food Additive), Product Type (Concentrates, Flower, leaves), Compound, Source, Distribution Channel, Application - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年大麻市場規模為327.3億美元,預計2024年將達417.7億美元,2030年將達到1872.4億美元,複合年成長率為28.29%。
大麻全球市場
主要市場統計 | |
---|---|
基準年[2023] | 327.3億美元 |
預測年份 [2024] | 417.7億美元 |
預測年份 [2030] | 1872.4億美元 |
複合年成長率(%) | 28.29% |
大麻市場上的大麻衍生產品包括但不限於乾燥花、濃縮物、食用品、外用品和大麻素,例如 THC(四氫大麻酚)和 CBD(大麻二酚)。大麻產業服務於各種最終用途領域,包括醫療保健、製藥、個人護理、食品和飲料等。在醫學領域,大麻用於緩解與慢性疼痛、癌症、癲癇和多發性硬化症等疾病相關的症狀。大麻的休閒用途提供了酒精和菸草等傳統休閒產品的替代品。大麻市場範圍包括全球和區域銷售、產品創新、供應鏈管理、監管狀況等。大麻市場成長的主要驅動力是日益合法化、擴大藥用用途以及擴大採用大麻作為消費品。此外,遺傳學和種植技術的進步以及大麻相關調查投資的增加也有助於市場擴張。大麻市場的最新潛在機會包括快速成長的 CBD 市場,特別是在健康和保健領域,整合區塊鏈以提高供應鏈透明度,以及探索新的輸送系統以提高生物有效性。創新在大麻注入產品(例如飲料和偏好產品)以及根據個人基因特徵量身定做的個人化大麻藥物領域尤其活躍。此外,為了吸引具有環保意識的消費者,我們將引入環保的種植和加工方法,並投資於消費者教育,以克服恥辱並告知負責任的使用。利用人工智慧和機器學習對種植和消費者偏好進行預測分析預計將推動市場成長。然而,不同司法管轄區存在複雜的監管障礙、高昂的合規成本以及大麻使用持續存在的污名化。此外,缺乏標準化的劑量和消費方法、黑市營運商的激烈競爭以及銀行和金融服務的障礙限制了市場潛力。
區域洞察
美洲擁有一個複雜且快速擴張的大麻市場,各州的法律體制略有不同,聯邦層級的法律框架幾乎沒有變化。消費者的需求因地區和人口而異,趨勢顯示對藥用大麻產品和合法州休閒大麻產品的需求顯著增加。顧客的購買行為顯示出對偏好和電子煙的強烈趨勢。雖然新專利的競爭加劇,特別是在種植技術和大麻素合成方面,但一些州已經開始了調查計畫。在亞太地區,中國和印度涉足大麻市場主要集中於生產大麻,這是一種非精神活性品種。中國是大麻衍生產品(包括紡織品和大麻二酚(CBD)萃取物)的最大生產國之一,但國內消費受到嚴格監管。另一方面,印度是一個有著古老文化聯繫的新興市場,但仍受到嚴格監管,並顯示出在醫學研究和阿育吠陀方面的應用潛力。在歐洲,大麻的監管環境較為分散,德國、義大利和荷蘭等國家在患者准入和產品多樣性方面處於領先地位,並且總體上正在走向更加開放的製藥市場。歐盟客戶的購買行為反映出人們對大麻潛在醫療益處的認知和接受程度不斷提高,從而導致對藥用大麻產品和相關研究的投資增加。
FPNV定位矩陣
FPNV 定位矩陣對於評估大麻市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對大麻市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1-市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2-市場開拓:我們深入研究利潤豐厚的新興市場,並分析它們在成熟細分市場中的滲透率。
3- 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4-競爭力評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。
5- 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1-大麻市場的市場規模和預測是多少?
2-大麻市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些?
3-大麻市場的技術趨勢和法律規範是什麼?
4-大麻市場主要供應商的市場佔有率是多少?
5-進入大麻市場的適當型態或策略手段是什麼?
[180 Pages Report] The Cannabis Market size was estimated at USD 32.73 billion in 2023 and expected to reach USD 41.77 billion in 2024, at a CAGR 28.29% to reach USD 187.24 billion by 2030.
Global Cannabis Market
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 32.73 billion |
Estimated Year [2024] | USD 41.77 billion |
Forecast Year [2030] | USD 187.24 billion |
CAGR (%) | 28.29% |
The cannabis market products derived from cannabis include but are not limited to dry flowers, concentrates, edibles, topicals, and cannabinoids such as THC (tetrahydrocannabinol) and CBD (cannabidiol). The cannabis industry serves various end-use sectors, such as healthcare, pharmaceuticals, personal care, and food & beverages. In the medical sector, cannabis is prescribed to alleviate symptoms associated with chronic pain, cancer, epilepsy, and multiple sclerosis, among others. The recreational use of cannabis provides an alternative to traditional leisure substances such as alcohol and tobacco. The scope of the cannabis market includes global and regional sales, product innovation, supply chain management, and regulatory landscapes. Cannabis market growth is predominantly driven by increasing legalization, growing medicinal applications, and the rising adoption of cannabis as a consumer good. Furthermore, advancements in genetics and cultivation technology, and increasing investment in cannabis-related research, contribute to the market's expansion. The latest potential opportunities within the cannabis market include the burgeoning CBD market, especially in the health and wellness sector, the integration of blockchain for supply chain transparency, and the exploration of new delivery systems to enhance bioavailability. Innovations are particularly thriving in areas of cannabis-infused products, such as beverages and edibles, as well as personalized cannabis medicines tailored to individual genetic profiles. Furthermore, implementing eco-friendly cultivation and processing methods to appeal to environmentally-conscious consumers and investing in consumer education to overcome stigma and inform about responsible use. Leveraging AI and machine learning for predictive analytics in cultivation and consumer preferences is expected to propel market growth. However, complex regulatory hurdles across different jurisdictions, high compliance costs, and the persistent stigmatization of cannabis use. In addition, the lack of standardized dosing and methods of consumption, significant competition from black-market operators, and hurdles in banking and financial services pose limitations to the market's potential.
Regional Insights
The Americas represents a complex and rapidly expanding cannabis market, differing minimally at the federal level but with nuanced legal frameworks across the states. Consumer needs vary significantly by region and demographics, with trends showing a substantial increase in demand for both medicinal and, in legal states, recreational cannabis products. Customer purchasing behavior demonstrates a strong inclination towards edibles and vapes. Several states have initiated research programs while the race for new patents is intense, particularly in cultivation tech and cannabinoid synthesis. In APAC, China's and India's involvement in the cannabis market is predominantly focused on the production of hemp, a non-psychoactive variety of cannabis. China is one of the largest producers of hemp-derived products such as textiles and cannabidiol (CBD) extracts, though consumption within the country remains strictly controlled. Meanwhile, India presents a nascent market with ancient cultural ties to cannabis, and while still heavily regulated, it shows potential for medical cannabis research and Ayurvedic applications. In Europe, the regulatory landscape for cannabis is fragmented but generally moving towards more open medicinal markets, with countries such as Germany, Italy, and the Netherlands leading in patient access and product diversity. The EU's customer purchasing behavior reflects a growing awareness and acceptance of the potential medical benefits of cannabis, leading to increased investment in pharmaceutical cannabis products and related research.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Cannabis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Cannabis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Cannabis Market, highlighting leading vendors and their innovative profiles. These include Acreage Holdings, Aphria, Inc., Aurora Cannabis Inc., Cannabis Science Inc., Canopy Growth Corporation, Chronos Group Inc., Cresco Labs, Inc., Curaleaf Holdings, Inc., CV Sciences Inc., EcoGen Biosciences, Elixinol Wellness Limited, Extractas Bioscience, Folium Europe B.V., Green Thumb Industries Inc., Lexaria Bioscience Corp., Medical Marijuana, Inc., MediPharm Labs Inc., Organigram Holdings Inc., Peace Naturals Project Inc., PharmaHemp d.o.o., StenoCare A/S, The Seed Cellar, and Tikun Olam.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Cannabis Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Cannabis Market?
3. What are the technology trends and regulatory frameworks in the Cannabis Market?
4. What is the market share of the leading vendors in the Cannabis Market?
5. Which modes and strategic moves are suitable for entering the Cannabis Market?